Patents by Inventor Giorgio Gribaudo

Giorgio Gribaudo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antipathogenic peptides
    Patent number: 8877738
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antipathogenic, in particular antiviral or/and antibacterial activity. In a preferred aspect, the peptide compounds of the invention have an activity in respect of a broad spectrum of viruses, both DNA and RNA viruses, irrespective of whether they possess virus envelope or not. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, i.e. for the treatment or prevention of pathogenic, in particular viral or/and bacterial infections.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 4, 2014
    Assignee: Spiderbiotech S.r.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo, Giorgio Gribaudo, David Lembo, Davide Gibellini
  • Antibodies against human cytomegalovirus (HCMV)
    Patent number: 8202518
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: June 19, 2012
    Assignee: Ribovax Biotechnologies S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • NOVEL ANTIPATHOGENIC PEPTIDES
    Publication number: 20120121623
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antipathogenic, in particular antiviral or/and antibacterial activity. In a preferred aspect, the peptide compounds of the invention have an activity in respect of a broad spectrum of viruses, both DNA and RNA viruses, irrespective of whether they possess virus envelope or not. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, i.e. for the treatment or prevention of pathogenic, in particular viral or/and bacterial infections.
    Type: Application
    Filed: August 5, 2010
    Publication date: May 17, 2012
    Applicant: SPIDERBIOTCH S.r.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo, Giorgio Gribaudo, David Lembo, Davide Gibellini
  • Antibodies against human cytimegalovirus (HCMV)
    Patent number: 8153129
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: April 10, 2012
    Assignee: Ribovax Biotechnologies S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • Antibodies Against Human Cytomegalovirus (HCMV)
    Publication number: 20110171233
    Abstract: The present invention provides novel antibodies sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Application
    Filed: July 31, 2008
    Publication date: July 14, 2011
    Applicant: RIBOVAX BIOTECHNOLOGIES S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • Antibodies Against Human Cytomegalovirus (HCMV)
    Publication number: 20100284916
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Application
    Filed: June 30, 2008
    Publication date: November 11, 2010
    Applicant: RIBOVAX BIOTECHNOLOGIES S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • Antibodies against Human Cytimegalovirus (HCMV)
    Publication number: 20100040602
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Application
    Filed: December 12, 2007
    Publication date: February 18, 2010
    Applicant: RIBOVAX BIOTECHNOLOGIES SA
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo